• Aller à la navigation (touche entrée).
  • Aller au contenu (touche entrée).
OK

Forgot Your Password?

My account
  • En
  • Fr
  • Jp

In-Cell-Art Universal nanotaxi® for vaccines and antibodies

  • About us
    • In-Cell-Art
    • Founders
    • Team
    • Careers
  • R & D
    • Technologies
    • Projects
    • Partnerships
    • Publications
  • ICANtibodies™
    • What's ICANtibodies™
    • Benefits
    • Achievements
  • ICA vaccine
    • DNA vaccine
    • RNA vaccine
    • Subunit vaccine
  • ICAFectin®
    • DNA transfection
    • siRNA transfection
    • Ordering
    • Publications
Mar 12, 2013

A Research Program with One of Top 10 Global Pharmas to Validate Targets for Potential Antibodies Medicines

Jan 01, 2013

In-Cell-Art starts 2013 in new facilities. New year, new laboratories for more innovation !!!

Dec 06, 2012

In-Cell-Art Announces Execution of Pilot Research Studies Agreement

Nov 12, 2012
In-Cell-Art ranked in the 4th position in the Biotech/Medical Sector of the national Deloitte Technology Fast 50 Award

Press release In-Cell-Art, Immeuble Bio-Ouest Halle 13, 21 rue de la Noue Bras de Fer, 44200 Nantes, France - Tel. +33 (0)2 40 71 67 17 - Fax +33 (0)2 72 88 22 01 - info@incellart.com

Copyright © 2013 InCellArt - Home - Legal terms